bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.05.01.651707

STREAMLINING HISTOPATHOLOGY: INSTAPRESERVE TISSUESAFE A SINGLE-STEP FIXATIVE THAT IMPROVES TISSUE QUALITY AND WORKFLOW EFFICIENCY

Vangala, R. K.·Vangala, A. B.·Kanukollu, S.·Sankarnarayanan, P. M.·Shankar, A.·Murugaian, E. E.
View original source ↗Export metadata ↓

Abstract

In clinical pathology, tissue processing is crucial in generating a valuable report for faster diagnosis. Formalin-fixed paraffin-embedded tissues are the standard specimens for clinical and molecular analyses. Though the demand persists for faster diagnosis, neutral buffered formalin (NBF) -based fixation and processing have not been replaced with a simple, faster, and user-friendly method. The alcohol-based fixatives were evaluated as an alternative to formalin, yet none have replaced formalin for various reasons. InstaPRESERVE Tissuesafe is an alcohol-based, biodegradable, and user-friendly fixative solution. The clinical specimens are well preserved and suitable for histopathology, genomics, and proteomics studies. The efficacy of instaPRESERVE Tissuesafe with ethanol or isopropyl alcohol and a modified tissue processing method without alcohol dehydration steps was studied. The pigs organs, brain, and liver tissues were fixed with NBF and InstaPRESERVE Tissuesafe solutions (ethanol/isopropyl alcohol). Based on the alcohol content of instaPRESERVE Tissuesafe, the dehydration step(s) were skipped during tissue processing. Serial sections from fixed tissues were processed and stained with H&E. The intactness of the sections with instaPRESERVE Tissuesafe fixation was comparable to that of NBF fixation. No autolysis/ decomposition was observed with InstaPRESERVE Tissuesafe (both) and NBF. The H&E staining scoring was satisfactory with well-preserved cell boundaries and organelles in both liver and brain tissue sections. The key factors of any fixative are its penetration, temperature, and time taken for fixation. In this study, the penetration rate of InstaPRESERVE Tissuesafe with either ethanol or isopropyl alcohol was the same as NBF within 6 to 12 hrs. The results indicated that increased concentration of alcohol in instaPRESERVE Tissuesafe did not affect the histology, and overall quality of the tissue sections processed was comparable to formalin fixation. The cytoplasmic and nuclear details, erythrocyte integrity, and lymphocytic appearance were well maintained. The time was reduced to 6 hrs from 9 hrs of the standard method. This study has addressed the modification of tissue processing with reduced time in histopathology with instaPRESERVE Tissuesafe. The outcome of this study has shown that instaPRESERVE Tissuesafe may be an alternative to formalin and helps in faster diagnosis.

Explore related subjects

pathologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vangala, R. K., Vangala, A. B., Kanukollu, S., Sankarnarayanan, P. M., Shankar, A., Murugaian, E. E.. 2025-05-08. STREAMLINING HISTOPATHOLOGY: INSTAPRESERVE TISSUESAFE A SINGLE-STEP FIXATIVE THAT IMPROVES TISSUE QUALITY AND WORKFLOW EFFICIENCY. https://doi.org/10.1101/2025.05.01.651707

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

NAE1-Dependent Protein Neddylation Preserves Endothelial Identity and Vascular Integrity

Background: Endothelial dysfunction is a central driver of cardiovascular and inflammatory diseases, yet the post-translational mechanisms that preserve endothelial homeostasis remain incompletely understood. Protein neddylation, the covalent conjugation of a ubiquitin-like modifier, regulates diverse cellular processes, yet its physiological role in the vascular endothelium remains unknown. This study investigated whether protein neddylation is required to preserve endothelial identity and vascular homeostasis. Methods: We generated tamoxifen-inducible endothelial-specific Nae1 knockout mice to inhibit neddylation and combined bulk RNA sequencing, single-cell and single-nucleus transcriptomics, quantitative proteomics, biochemical analyses, and gain- and loss-of-function approaches to define the role of endothelial neddylation in vascular homeostasis and inflammatory injury. Results: Endothelial-specific Nae1 deletion caused rapid mortality associated with vascular leakage, platelet accumulation, inflammation, and multi-organ injury. Multi-omics analyses demonstrated profound loss of endothelial identity, characterized by suppression of core endothelial programs and activation of inflammatory, procoagulant, and pyroptotic pathways. Single-cell analyses revealed progressive endothelial dysfunction culminating in depletion of the endothelial population and remodeling of the vascular niche. Mechanistically, endothelial neddylation deficiency activated gasdermin D (GSDMD)- and gasdermin E (GSDME)-dependent pyroptosis, whereas dual inhibition of GSDMD and GSDME markedly attenuated inflammatory transcriptomic remodeling, vascular injury, hepatocyte death, immune cell infiltration, and platelet accumulation. Translational analyses demonstrated reduced endothelial neddylation in experimental endotoxemia and decreased expression of neddylation pathway components in human atherosclerosis and COVID-19 datasets. Conversely, restoration of endothelial neddylation partially reversed inflammatory endothelial transcriptomic reprogramming in vivo. Conclusions: NAE1-dependent protein neddylation is an essential regulator of endothelial identity and vascular integrity. Loss of endothelial neddylation promotes gasdermin-dependent pyroptosis and thrombo-inflammatory vascular injury, whereas restoration of the neddylation pathway mitigates inflammatory endothelial dysfunction. These findings identify endothelial neddylation as a fundamental mechanism maintaining vascular homeostasis and a potential therapeutic target for cardiovascular and inflammatory diseases.

pathology↗
bioRxiv2025

EPHB2 promotes diet-induced MASH liver fibrosis

The EphB2 receptor tyrosine kinase is thought to participate in numerous fibroinflammatory disorders. In metabolic dysfunction-associated steatohepatitis (MASH), we find EphB2 becomes strongly overexpressed and overactive in hepatic stellate cells (HSCs) from humans with the disease and from mice fed liver-injuring high fat diets. Genetic deletion of EphB2 or inactivation of its tyrosine kinase catalytic domain suppressed diet-induced MASH fibrosis, while a kinase overactive point mutant displayed exacerbated steatosis and hepatic damage. Silencing EphB2 in primary HSCs dampened the ability of TGF-{beta}/SMAD signals to stimulate the transdifferentiation of stellate cells into profibrotic myofibroblasts, and HSC-specific deletion of the receptor, but not hepatocyte deletion, reduced liver scarring in multiple mouse models, even after fibrosis was established. Finally, a newly developed small molecule tetramerization inhibitor that targets EphB2-Ephrin receptor-ligand interactions effectively blunts inflammation and fibrosis in chemical and diet-induced liver injury models, demonstrating that therapeutically targeting EphB2 can counter MASH fibrosis.

pathology↗
bioRxiv2025

Cardiac Hemorrhage Precedes Hypertension-induced Fibrosis inPlasminogen Activator Inhibitor-1 Deficient Mice

AimsPlasminogen activator inhibitor-1 (PAI-1) regulates plasmin-mediated proteolysis, thereby influencing vascular stability and tissue remodeling. Angiotensin II (AngII) induces an increase in PAI-1 during the development of ascending thoracic aortic aneurysm (ATAA). The initial purpose of this study was to determine whether deletion of PAI-1 influenced development of ATAA. Subsequently, this study aimed to define the early pathological events preceding cardiac fibrosis in PAI-1 deficiency and the structural domain responsible for its protective effect. Methods and resultsAngII was infused for 4 weeks in whole-body PAI-1 deficient (PAI-1-/-) mice and their wild-type littermates (PAI-1+/+) to examine the role of PAI-1 in ATAA. PAI-1 deficiency did not alter AngII-induced aortopathy but revealed a striking cardiac phenotype characterized by replacement fibrosis predominantly within the epicardium and posterior septum. Ferric iron, indicative of prior hemorrhage, was coincident with fibrosis. Similar phenotypes were observed in PAI-1-/- mice infused with norepinephrine for 4 weeks. To define the pathological events preceding cardiac fibrosis, either AngII or norepinephrine was infused for 1 week in PAI-1+/+ or -/- mice. Both infusions induced extensive epicardial hemorrhage and posterior septal fibrosis in PAI-1-/- mice. To explore the initiation of cardiac pathology, AngII was infused for approximately 1 day. PAI-1-/- mice developed diffuse hemorrhage and cardiomyocyte injury localized to the posterior septum, pathologic changes that preceded overt fibrosis. Finally, to determine the protective domain of PAI-1, saline or AngII was administered to mice harboring loss-of-function point mutations in the protease inhibitory (PAI-1Ala/Ala) or somatomedin B-binding domains (PAI-1AK/AK). Compared to saline infusion, 1 week of AngII induced hemorrhage and heterogeneous fibrosis in PAI-1Ala/Ala, but not PAI-1AK/AK mice. ConclusionsThese findings support that, under hemodynamic stress, PAI-1 deficiency promotes early cardiac hemorrhage and cardiomyocyte injury that lead to fibrosis. Mutational studies implicate dysregulated plasmin generation as an initiator of cardiac injury and fibrosis. TRANSLATIONAL PERSPECTIVECardiac fibrosis has been reported in a human population with PAI-1 deficiency and currently lacks targeted therapy. Our findings demonstrate that in animal models, PAI-1 deficiency confers susceptibility to cardiac injury in response to hemodynamic stress, which may accelerate fibrotic remodeling. Mutational disruption of the protease-inhibitory domain of PAI-1 induced similar pathology, supporting a protective role for this function. These observations suggest that interventions aimed at controlling hypertension, promoting endothelial integrity, or regulating plasmin activation could reduce fibrotic remodeling in this population.

pathology↗